London Biotechnology Show

London Biotechnology Show Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from London Biotechnology Show, Biotechnology company, Clarence Centre 6 St. George's Circus, London.

The London Biotechnology Show is Europe’s flagship biotechnology event, connecting global leaders across red biotech to accelerate innovation, partnerships, and investment shaping the future of healthcare and life sciences.

The London Biotechnology Show 2026 continues to strengthen its global media network with the addition of IBI Journal as ...
31/07/2026

The London Biotechnology Show 2026 continues to strengthen its global media network with the addition of IBI Journal as an official Media Partner.

IBI provides the biopharmaceutical industry with comprehensive coverage of key scientific, technology, regulatory and business topics. The editorial mix of peer-reviewed papers, practical advice on managing bioprocessing and technology, regulatory and business columns, and expert commentary provides comprehensive coverage of upstream and downstream processing, manufacturing operations, regulations, formulation, scale-up/technology transfer, drug delivery, analytical testing and more.

Register today and be part of the conversation: https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others

We are pleased to welcome Surplus Solutions as an Exhibitor at the London Biotechnology Show 2026.Since 2006, Surplus So...
28/07/2026

We are pleased to welcome Surplus Solutions as an Exhibitor at the London Biotechnology Show 2026.

Since 2006, Surplus Solutions has been a global provider of lifecycle solutions for pre-owned laboratory equipment, serving the biotechnology, pharmaceutical, and life sciences industries. Through established auction and direct sales channels, the company delivers reliable, high-quality, and cost-effective equipment solutions to organisations worldwide.

Supported by expert sourcing capabilities and comprehensive refurbishment, repair, maintenance, and logistics services, Surplus Solutions helps customers maximise the value of their laboratory assets while ensuring access to dependable equipment for research, development, and manufacturing operations.

With a commitment to sustainability and operational excellence, Surplus Solutions enables organisations to accelerate innovation, reduce costs, and minimise environmental impact. Its mission is to help customers bring life-saving products to market faster, more affordably, and in a more environmentally responsible way.

Connect with Surplus Solutions and discover innovative solutions supporting the biotechnology and life sciences industry at the London Biotechnology Show 2026.

Take advantage of our 𝐋𝐨𝐧𝐝𝐨𝐧 𝐒𝐮𝐦𝐦𝐞𝐫 𝐒𝐚𝐯𝐢𝐧𝐠𝐬 and save 𝟐𝟎% 𝐨𝐧 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐨𝐫 & 𝐒𝐩𝐨𝐧𝐬𝐨𝐫𝐬𝐡𝐢𝐩 𝐏𝐚𝐜𝐤𝐚𝐠𝐞𝐬 for a limited time.

Secure your space today: https://londonbiotechshow.com/register/?t=exhibitor&utm_campaign=social_media&utm_medium=others&utm_source=others

We are pleased to welcome Puja Myles,Director, Clinical Practice Research Datalink (CPRD) atMedicines and Healthcare pro...
27/07/2026

We are pleased to welcome Puja Myles,Director, Clinical Practice Research Datalink (CPRD) atMedicines and Healthcare products Regulatory Agency (MHRA), to the distinguished speaker lineup at London Biotechnology Show 2026.

Dr Puja Myles is Director of the Medicines and Healthcare products Regulatory Agency’s (MHRA) real world data research service, the Clinical Practice Research Datalink (CPRD). She is a public health specialist and epidemiologist. Her current work focuses on regulatory science and policy in relation to real world data (RWD) and real world evidence (RWE), especially novel approaches and data quality.

Hear from Puja Myles and many more experts at . Register as a delegate now and save up to 40% : https://londonbiotechshow.com/register?t=delegate&utm_campaign=LinkedIn&utm_medium=social-media&utm_source=linkedin

From increased funding and commercialisation initiatives to breakthroughs in life sciences and stronger industry collabo...
22/07/2026

From increased funding and commercialisation initiatives to breakthroughs in life sciences and stronger industry collaboration, the latest UK Research & Innovation (UKRI) Annual Report highlights the factors shaping a more resilient and competitive biotechnology ecosystem.

Swipe through to explore some of the key insights and what they could mean for the future of biotech innovation.

Join the conversations shaping the future of biotechnology at the London Biotechnology Show 2026.

Secure your spot today: https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others

We are pleased to welcome Daniel Hickmore, Head of Strategy and Sales Research & Clinical EMEA LS at Amazon Web Services...
21/07/2026

We are pleased to welcome Daniel Hickmore, Head of Strategy and Sales Research & Clinical EMEA LS at Amazon Web Services (AWS), to the distinguished speaker lineup at London Biotechnology Show 2026.

Daniel leads AWS's strategic engagement with pharmaceutical and life sciences R&D organisations across EMEA and APJ. He works closely with global pharma companies on AI-driven clinical development, real-world evidence platforms, and agentic automation for drug discovery and clinical operations. With deep expertise spanning data strategy, regulatory-grade cloud infrastructure, and cross-industry innovation in healthcare, Daniel brings a practitioner's perspective on how technology is reshaping clinical trials and biopharma R&D.

Hear from Daniel Hickmore and many more experts at . Register as a delegate now and save up to 40% : https://londonbiotechshow.com/register?t=delegate&utm_campaign=LinkedIn&utm_medium=social-media&utm_source=linkedin

𝐎𝐧𝐥𝐲 𝟏𝟎 𝐃𝐚𝐲𝐬 𝐋𝐞𝐟𝐭 𝐭𝐨 𝐬𝐚𝐯𝐞 𝐨𝐧 𝐲𝐨𝐮𝐫 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐋𝐨𝐧𝐝𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐒𝐡𝐨𝐰 𝟐𝟎𝟐𝟔.Whether you're looking to showcase you...
20/07/2026

𝐎𝐧𝐥𝐲 𝟏𝟎 𝐃𝐚𝐲𝐬 𝐋𝐞𝐟𝐭 𝐭𝐨 𝐬𝐚𝐯𝐞 𝐨𝐧 𝐲𝐨𝐮𝐫 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐋𝐨𝐧𝐝𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐒𝐡𝐨𝐰 𝟐𝟎𝟐𝟔.

Whether you're looking to showcase your innovations, strengthen your brand presence, or gain insights from the leaders shaping the future of biotechnology, now is the time to secure your place.

𝐒𝐚𝐯𝐞 𝟐𝟎% 𝐨𝐧 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 & 𝐒𝐩𝐨𝐧𝐬𝐨𝐫𝐬𝐡𝐢𝐩 𝐏𝐚𝐜𝐤𝐚𝐠𝐞𝐬.
𝐒𝐚𝐯𝐞 𝐮𝐩 𝐭𝐨 𝟒𝟎% 𝐨𝐧 𝐃𝐞𝐥𝐞𝐠𝐚𝐭𝐞 𝐏𝐚𝐬𝐬𝐞𝐬.

Register today and be part of the conversations, collaborations, and innovations driving the future of biotechnology.

🔗 Secure your place now: https://londonbiotechshow.com/register?t=enquiry&utm_campaign=linked_in&utm_medium=social_media&utm_source=linkedin

June 2026 demonstrated that biotechnology continues to be driven by strategic partnerships, investment, and scientific i...
17/07/2026

June 2026 demonstrated that biotechnology continues to be driven by strategic partnerships, investment, and scientific innovation.

From multi-billion-dollar acquisitions to licensing agreements across RNA therapeutics and next-generation drug development, the month's biggest deals reflect a shared focus on accelerating innovation and bringing transformative therapies to patients.

Swipe through to explore some of the key biotech deal highlights from June 2026 and the trends shaping the industry's next chapter.

Be part of the conversations driving biotechnology forward at the London Biotechnology Show 2026.

Secure your spot today: https://londonbiotechshow.com/register?utm_campaign=Social+media&utm_medium=others&utm_source=others

UK Research and Innovation (UKRI) has launched a new five-year strategy aimed at strengthening the UK's research and inn...
16/07/2026

UK Research and Innovation (UKRI) has launched a new five-year strategy aimed at strengthening the UK's research and innovation ecosystem, with a major focus on artificial intelligence, life sciences, quantum technologies, and clean energy. Supported by the government's record £38.6 billion investment in research and development, the roadmap is designed to accelerate scientific discovery, boost economic growth, and reinforce the UK's position as a global innovation leader.

Read more at: https://londonbiotechshow.com/blog/ukri-unveils-five-year-strategy-to-accelerate-ai-life-sciences-and-future-technologies

We are pleased to welcome  Wesley Straub, Head of Protein Science Solutions at MilliporeSigma, to the distinguished spea...
15/07/2026

We are pleased to welcome Wesley Straub, Head of Protein Science Solutions at MilliporeSigma, to the distinguished speaker lineup at London Biotechnology Show 2026.

Wesley Straub obtained his B.S. in Chemistry magna cm laude from Boston University and a Ph.D. from the University of California San Francisco. After working on the production, purification and characterization of several biosimilars, recombinant blood factors and novel biotherapeutics, he entered the life science technology with Forte Bio. He has contributed to the development and launch of over 25 hardware, software and reagent products across BLI, capillary sequencing, qPCR and high sensitivity technologies such as the FemtoQuest™ System with SMC® Technology.

From genomics and precision medicine to AI-driven innovation and next-generation therapeutics, hear from the experts shaping the future of biotechnology.

🔗 Register as a delegate now and save up to 40% : https://londonbiotechshow.com/register?t=delegate&utm_campaign=LinkedIn&utm_medium=social-media&utm_source=linkedin

Address

Clarence Centre 6 St. George's Circus
London

Alerts

Be the first to know and let us send you an email when London Biotechnology Show posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to London Biotechnology Show:

Shortcuts

Featured

Share